歐康維視生物-B(01477.HK):周慶齡獲委任為聯席公司祕書及授權代表等職
格隆匯6月15日丨歐康維視生物-B(01477.HK)公吿,董事會獲悉公司聯席公司祕書孫佩真已辭任Vistra Corporate Services(HK) Limited(公司外部企業服務供應商)的企業服務經理。由於上述辭任,孫不再擔任(i)聯席公司祕書;(ii)根據香港聯合交易所有限公司證券上市規則第3.05條所規定的公司授權代表;及(iii)根據上市規則第19.05(2)條及公司條例(香港法例第622章)第16部所規定的代公司於香港接受法律程序送達文件及通知書的公司授權代表,自2022年6月15日起生效。
董事會欣然宣佈,周慶齡已獲委任為聯席公司祕書、授權代表及法律程序代理人,自2022年6月15日起生效。季芸將繼續擔任另一位聯席公司祕書。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.